Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03539328
Title Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (MITO27)
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

ovarian cancer

fallopian tube cancer

peritoneum cancer


Gemcitabine + Paclitaxel + Pegylated liposomal-doxorubicin

Gemcitabine + Paclitaxel + Pegylated liposomal-doxorubicin + Pembrolizumab

Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
National Cancer Institute Milan 20133 Italy Details
*Shaded cells indicate that there was no data available from for the field